HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammed Shahid Selected Research

asenapine

3/2012Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
10/2011Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation.
4/2011Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
12/2010Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
11/2010Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors.
4/2010Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.
12/2009Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania.
11/2009Asenapine effects in animal models of psychosis and cognitive function.
6/2009Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
5/2009Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammed Shahid Research Topics

Disease

24Schizophrenia (Dementia Praecox)
12/2017 - 08/2005
13Bipolar Disorder (Manic Depressive Psychosis)
03/2012 - 02/2008
5Cognitive Dysfunction
03/2021 - 01/2009
4Mental Disorders (Mental Disorder)
12/2017 - 01/2008
3Catalepsy
05/2012 - 02/2008
3Neurobehavioral Manifestations
12/2010 - 02/2008
2Depressive Disorder (Melancholia)
05/2010 - 01/2008
1Brain Diseases (Brain Disorder)
12/2020
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Carcinogenesis
01/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2017
1Memory Disorders (Memory Loss)
01/2017
1Treatment-Resistant Schizophrenia
11/2016
1Neoplasms (Cancer)
01/2016
1Adenocarcinoma
01/2016
1Carcinoma (Carcinomatosis)
01/2016
1Cholangiocarcinoma
01/2016
1Stroke (Strokes)
10/2015
1Cardiovascular Diseases (Cardiovascular Disease)
10/2015
1Postoperative Nausea and Vomiting (PONV)
09/2015
1Vomiting
09/2015
1Nausea
09/2015
1Pain (Aches)
09/2015
1Postoperative Pain
09/2015
1Drug-Related Side Effects and Adverse Reactions
09/2015
1Wounds and Injuries (Trauma)
05/2015
1Neurofibromatoses (Neurofibromatosis)
05/2015
1Hypoglycemia (Reactive Hypoglycemia)
01/2015
1Ventricular Fibrillation
07/2014
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2012
1Anxiety Disorders (Anxiety Disorder)
02/2012
1Panic Disorder (Panic Attack)
02/2012
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
02/2012
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2012
1Phobic Disorders (Phobia)
02/2012
1Anhedonia
10/2011
1Bacterial Infections (Bacterial Infection)
01/2011
1Bronchogenic Carcinoma
01/2011
1Mycoses (Diseases, Fungus)
01/2011
1Mania (Manias)
12/2009
1Psychotic Disorders (Schizoaffective Disorder)
11/2009
1Urinary Tract Infections (Urinary Tract Infection)
03/2007

Drug/Important Bio-Agent (IBA)

14asenapineFDA Link
03/2012 - 02/2008
11Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 02/2008
5Pharmaceutical PreparationsIBA
01/2017 - 07/2009
4Dopamine (Intropin)FDA LinkGeneric
11/2015 - 06/2009
4Org 26576IBA
12/2012 - 08/2005
4AMPA Receptors (AMPA Receptor)IBA
12/2012 - 08/2005
4Phencyclidine (Angel Dust)IBA
03/2012 - 07/2009
3ORM-10921IBA
03/2021 - 11/2016
3Serotonin (5 Hydroxytryptamine)IBA
03/2012 - 11/2008
3Adrenergic Agents (Adrenergic Drugs)IBA
04/2010 - 05/2009
2ORM-12741IBA
12/2020 - 01/2017
2LigandsIBA
12/2017 - 01/2017
2Antidepressive Agents (Antidepressants)IBA
01/2017 - 10/2011
2Clozapine (Clozaril)FDA LinkGeneric
11/2016 - 11/2008
2Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2016 - 03/2011
2Glutamic Acid (Glutamate)FDA Link
12/2012 - 02/2012
21-(benzofurazan-5-ylcarbonyl)piperidineIBA
05/2012 - 08/2005
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2012 - 11/2010
2LithiumIBA
03/2012 - 04/2011
2Valproic Acid (Depakote)FDA LinkGeneric
03/2012 - 04/2011
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2020
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1MagnesiumIBA
01/2018
1Imipramine (Janimine)FDA LinkGeneric
01/2017
1Haloperidol (Haldol)FDA LinkGeneric
11/2016
1AlbuminsIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2015
1Angiotensin Receptor AntagonistsIBA
10/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2015
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2015
1Tramadol (K315)FDA LinkGeneric
09/2015
1Acetaminophen (Paracetamol)FDA LinkGeneric
09/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2015
1DiamondIBA
07/2014
1Risperidone (Risperdal Consta)FDA LinkGeneric
05/2012
1Glycine (Aminoacetic Acid)FDA LinkGeneric
05/2012
1propionic acid (potassium propionate)IBA
05/2012
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
05/2012
1N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA
05/2012
1N-Methylaspartate (NMDA)IBA
03/2012
1Ionotropic Glutamate ReceptorsIBA
02/2012
1Anti-Anxiety Agents (Anxiolytics)IBA
02/2012
1AcidsIBA
12/2011
1Nerve Growth Factors (Neurotrophins)IBA
03/2011
1Cholinergic Agents (Cholinergics)IBA
04/2010
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
04/2010
1Serotonin ReceptorsIBA
07/2009
1alpha-2 Adrenergic ReceptorsIBA
06/2009
1Anti-Bacterial Agents (Antibiotics)IBA
03/2007

Therapy/Procedure

5Therapeutics
10/2015 - 01/2008
2Drug Therapy (Chemotherapy)
10/2015 - 05/2010
1Laparotomy
09/2015
1Debridement
05/2015
1Spinal Anesthesia
05/2015